Business

Cronus Pharma Launches First FDA-Approved Bioequivalent Robenacoxib Injection for Veterinary Use

Financial Post · August 26, 2026 at 6:03 a.m.

First bioequivalent to ONSIOR ® (robenacoxib) Injection equips veterinarians with new, cost-effective NSAID (nonsteroidal anti-inflammatory) option for controlling postoperative pain and inflammation with certain surgical procedures in dogs and cats.

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

Cronus Pharma Launches First FDA-Approved Bioequivalent Robenacoxib Injection for Veterinary Use

More from Financial Post

New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 2026

Snow Alert: It’s Snowing in Ikon Pass Country

William Watson: Let’s see the last draft. Inquiring voters want to know

Opinion: We need to reduce wildfire fuel and zone better

More in Business

New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 2026

Snow Alert: It’s Snowing in Ikon Pass Country

Old soup factory takes on new high-tech life as quantum computing firm gets $195M federal boost

William Watson: Let’s see the last draft. Inquiring voters want to know

Opinion: We need to reduce wildfire fuel and zone better

Zacatecas Silver Closes the Second Tranche of Non-Brokered Private Placement